Astellas Flashes Cash For Ogeda's Women's Health Drug

 
• By Lucie Ellis-Taitt
  
Euro currency
Astellas pays €500m upfront to acquire Ogeda for its Phase II hot flash treatment
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business